scispace - formally typeset
Journal ArticleDOI

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

Reads0
Chats0
TLDR
Artemisinins are potent and rapidly acting antimalarial drugs, and their widespread use for treating patients with Plasmodium falciparum malaria raises the question of emerging drug resistance.
Abstract
To the Editor: Although artemisinins are potent and rapidly acting antimalarial drugs, their widespread use for treating patients with Plasmodium falciparum malaria raises the question of emerging drug resistance.1,2 Artemisinin monotherapy should not be used in areas where malaria is endemic; it requires an extended administration period and may lead to treatment failure, most frequently because of problems with compliance. Recent reports of high failure rates associated with artemisinin-based combination therapy, as well as in vitro drug-susceptibility data, suggest the possibility of clinical artemisinin resistance along the Thai–Cambodian border.3,4 We studied the potential emergence of artemisinin resistance using . . .

read more

Citations
More filters
Journal ArticleDOI

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Elizabeth A. Ashley, +82 more
TL;DR: Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing, and the incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.
References
More filters
Journal ArticleDOI

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6

TL;DR: A rise in resistance to artemisinin derivatives in field isolates indicates the need for increased vigilance and a coordinated and rapid deployment of drug combinations.
Journal ArticleDOI

Artemisinins: their growing importance in medicine

TL;DR: This safe and cheap drug class that saves lives at risk from malaria can also have important potential in oncology, and recent advances in defining the role of artemisinins are discussed.
Journal ArticleDOI

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.

TL;DR: The objective is to monitor the efficacy of anti‐malarial treatments in Thailand and to establish a protocol for evaluating the safety and effectiveness of these treatments against infectious diseases.
Journal ArticleDOI

Artemisinin resistance: how can we find it?

TL;DR: Since 2001, 40 countries have officially adopted artemisinin-based combination therapy for treating Plasmodium falciparum malaria and 20 have adopted the combination of artemether and lumefantrine as their first- or second-line treatment.
Related Papers (5)

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Elizabeth A. Ashley, +82 more